Home
About
Mission
Leadership
Research
Discovery Teams
Areas of Focus
Outreach
Drug Discovery Online
Community Outreach
Warren Center Lecture Series
News
Careers
Funding
Contact
Invest
Apr
13
Apr 13
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
Guest User
by: Research News @ Vanderbilt University
Sep 7
New Dystonia Drug Candidates Discovered
Feb 25
Soleno Therapeutics announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K (ATP) Channel Activators for the Treatment of Rare Diseases.